Neukio Biotherapeutics Co

BiotechnologySeries AShanghai, Chinaneukio.com

Latest round

Series A

Last raised

Sep 2022

Total raised

$90M

Investors

6

About Neukio Biotherapeutics Co

Based in Shanghai, China, and established in 2021, Neukio Biotherapeutics Co, Ltd. operates as a biopharmaceutical company that focuses on the development of allogeneic cell therapy for tumors. Richard Liqun Wang, the company's founder, served as CEO of Fosun Kite Biotech, and completed the commercialization of CAR-T products in less than three years. Moreover, it is equipped with 60,000 square meters of R&D and manufacturing centre. Neukio Biotherapeutics Co, Ltd. engages in the R&D of cell immune therapy for tumors based on modular and genetic technologies. The cell pipeline includes natural killer cells (Nk), and induced pluripotent stem cells (iPSC).

Who invested in Neukio Biotherapeutics Co

6 investors across 2 rounds

See all investors in Neukio Biotherapeutics Co

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Sep 2, 2022

    Amount

    $50M

    Investors

    Locked

  2. Angel

    Jul 29, 2021

    Amount

    $40M

    Investors

    Locked

Questions about Neukio Biotherapeutics Co

Who invested in Neukio Biotherapeutics Co?

Neukio Biotherapeutics Co has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Neukio Biotherapeutics Co raised?

Neukio Biotherapeutics Co has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Neukio Biotherapeutics Co last raise money?

Neukio Biotherapeutics Co's most recent round on record is a Series A, in Sep 2022.

What does Neukio Biotherapeutics Co do?

Based in Shanghai, China, and established in 2021, Neukio Biotherapeutics Co, Ltd.

Where is Neukio Biotherapeutics Co headquartered?

Neukio Biotherapeutics Co is headquartered in Shanghai, China.

Which VCs invest in companies like Neukio Biotherapeutics Co?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Neukio Biotherapeutics Co's stage. Their profiles are linked below.

Raising like Neukio Biotherapeutics Co? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.